What was BioNTech SE's revenue in 2025?

BioNTech SE reported $3.2B in revenue for fiscal year 2025. This represents a +5.7% change compared to 2024. Revenue edged up 5.7 percent versus 2024, a modest rebound after three consecutive years of pandemic-driven contraction in COVID-19 vaccine sales.

How did BioNTech SE's revenue change from 2024 to 2025?

BioNTech SE revenue grew from $3.0B in 2024 to $3.2B in 2025, a change of 5.7%.

Was 2025 BioNTech SE's best revenue year?

No. BioNTech SE's highest recorded revenue year was 2022 at $18.9B. In 2025, BioNTech SE reported $3.2B.

What was BioNTech SE's highest ever annual revenue?

BioNTech SE's highest ever annual revenue was $18.9B recorded in fiscal year 2022.

BioNTech SE

Biotechnology / ImmunotherapyFounded 2008

Reviewed by Swet Parvadiya

Last reviewed: July 2025

Explore BioNTech SE

Core profile pages, annual revenue records, and related research hubs for this company.

Annual Revenue

BioNTech SE Revenue in 2025

FY2025 Revenue

$3.2B

▲ 5.7% vs FY2024 ($3.0B)

Source: Annual report / company filing

BioNTech SE reported $3.2B in revenue for fiscal year 2025. This represents a growth of 5.7% compared to the 2024 figure of $3.0B.

Revenue edged up 5.7 percent versus 2024, a modest rebound after three consecutive years of pandemic-driven contraction in COVID-19 vaccine sales.

Revenue by Year

FY2025 FY2024 FY2023 FY2022

BioNTech SE Annual Revenue History

Year	Revenue	YoY Change
FY2025	$3.2B	+5.7%
FY2024	$3.0B	-27.9%
FY2023	$4.2B	-78.0%
FY2022	$18.9B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2024: $3.0B

Explore BioNTech SE

Core profile pages, annual revenue records, and related research hubs for this company.